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Abstract The present study demonstrates, in both hybrid
NG108-15 and mouse neuroblastoma N18TG2 cells, the presence
and regulation of PDE5 mRNA during cell differentiation.
PDE5 cDNA probes in Northern blot analysis recognize a V9
kb transcript in bovine lung as well as in mouse neuroblastoma
cells. Hybridization on total RNA extracted from dibutyryl-
cAMP-treated NG108-15 cells shows a 5-fold increase of PDE5
9 kb mRNA: such an increase is not observed in N18TG2
although we observed a similar increase in the enzymatic activity
of both cell lines. Our data demonstrate that PDE5 gene
expression can be regulated by cAMP and suggest the existence
of a complex regulatory system for PDE5 activity.
z 1999 Federation of European Biochemical Societies.
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1. Introduction
cAMP has been suggested to play a critical role in the
nervous system development [1^11]. On the other hand, the
signalling cascade activated by cAMP is also capable of inter-
acting with the cGMP pathway [12,13].
Phosphodiesterases (PDEs) are recognized as important el-
ements in the cyclic nucleotide signalling system [14^16]. In
the nervous system, as in other tissues, more than one PDE
isoenzymes are expressed [14]. Among them, little is known on
PDE5 (cGMP-binding cGMP-speci¢c) expression in the nerv-
ous system. It has been described in neuronal cell lines [17,18],
in rat superior cervical ganglion [19] and in cerebellum Pur-
kinje cells [20].
PDE5 is a homodimer of two V100 kDa subunits, ¢rst
puri¢ed and characterized from rat [21] and bovine lung
[22]. PDE5 cloning data [20,23^26] con¢rm that the monomer
contains two allosteric cGMP-binding sites, whose function is
still unknown. In spite of the extensive characterization and
distribution studies of PDE families, no clear correlation has
been demonstrated between a given PDE isoenzyme and a
speci¢c neuronal function, with the exception of PDE6 in
the visual system [27].
The major hindrance in establishing a functional role for
PDE isoforms can be ascribed to the brain cellular and func-
tional complexity. Mouse neuroblastoma lines have been
widely used as model system of homogeneous cell popula-
tions. Two lines, N18TG2 and the derived NG108-15
(108CC15) neuroblastoma U glioma hybrid, appear particu-
larly interesting for their di¡erent abilities to express neuro-
speci¢c markers [28^32]. This had led to consider them as
representative of two phases of neurone di¡erentiation, re-
spectively characterized by ¢ber formation and synaptogene-
sis.
We have previously shown that two PDE isoforms, PDE4
and PDE5, are expressed in both cell lines and their activity is
induced by dbcAMP [18]. The cAMP level is known to regu-
late the transcription of many genes, among these transcrip-
tional regulation of PDE4 activity has been reported as a
feedback regulatory response to increased cellular cAMP level
[33,34]. Although regulation of PDE5 activity by cAMP
through PKA phosphorylation has been reported in the res-
piratory system [35,36], no evidence of transcriptional regula-
tion of PDE5 by cAMP has been described so far. Thus it
appeared of interest to establish whether cAMP may act as an
activator of PDE5 transcription gene(s), as well as for PDE4.
To this aim, we produced PDE5-speci¢c cDNA probes by
reverse transcriptase polymerase chain reaction (RT-PCR).
Here we report the results of Northern blot analysis of
PDE5-mRNA levels in neuroblastoma cells maintained in
basal and di¡erentiating (dbcAMP treatment) conditions.
2. Materials and methods
2.1. Cell cultures
N18TG2 and NG108-15 cells were cultured as previously described
[18]. 3.5U105 cells were plated on 90 mm culture dishes (Falcon). 24 h
after plating, the medium was replaced with either DMEM supple-
mented with 10% FCS (control) or supplemented with 1% FCS and
5 mM dbcAMP (N6,2P-o-dibutyryladenosine 3P :5P-cyclic monophos-
phate, Sigma Chemical) and changed after an additional 72 hrs.
Five days after dbcAMP addition, both control and treated cells
were washed twice with PBS and stored at 380‡C.
2.2. PDE assay
Extraction of the PDE activity was performed as previously de-
scribed [18]. Cells were homogenized at 4‡C on 20 mM Tris-HCl
bu¡er pH 7.2, containing 0.2 mM EGTA, 5 mM MgCl2, 1 mM
phenylmethylsulfonyl£uoride (PMSF), 5 mM L-mercaptoethanol, 10
Wg/ml leupeptin, 5 Wg/ml bestatin, 10 Wg/ml pepstatin A, 0.1% Triton
X-100, in a glass-te£on homogenizer with 20 strokes. Homogenates
were centrifuged at 100 000Ug for 45 min at 4‡C, pellets were resus-
pended in homogenization bu¡er and centrifuged at 100 000Ug for 45
min: the ¢rst and second supernatants were pooled. Triton was in-
cluded in the homogenisation bu¡er in order to ensure the recovery of
membrane-associated PDE activity [17]. PDE activity was determined
with the two step method as described by Thompson and Appleman
[37] in a ¢nal volume of 0.3 ml of assay bu¡er (60 mM HEPES pH
7.2, 0.1 mM EGTA, 5 mM MgCl2, 0.5 mg/ml BSA, 30 Wg/ml soybean
trypsin inhibitor) using [3H]cAMP (speci¢c activity 28 Ci/mmol) or
[3H]cGMP (speci¢c activity 16.8 Ci/mmol) (Amersham) as a substrate
at a ¢nal concentration of 1 WM.
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2.3. Isolation of total and poly-A+ RNAs
Total RNA was prepared from bovine lung tissue and neuroblas-
toma cells using TRIzol reagent according to the manufacturer’s in-
structions (Life Technologies). poly-A RNA was puri¢ed from total
RNA preparations using an oligo(dT) cellulose column according to
the method described by Sambrook et al. [38].
2.4. RT-PCR
RT-PCR analysis was performed with the Stratagene RT-PCR kit
using Pfu DNA polymerase or Taq plus DNA polymerase (Strata-
gene). The ¢rst strand cDNA was synthesized by reverse transcription
of total RNA (2^6 Wg) or poly-A RNA (0.3 Wg) from bovine lung
and N18TG2 or NG108-15 total RNA (9 Wg) using random hexamers.
Controls, omitting reverse transcriptase, were included in the reac-
tions. The following PCR sense and antisense primers designed on
the bovine lung PDE5 cDNA clone [23] were used and conventionally
denoted respectively MI (5P-GGT TTG ATA ATG ATG AAG GGG
ACCA-3P : nucleotides 487^511) and MII (5P-CAT CAC GTT CCC
GTG TTA AAG TATC-3P : nucleotides 1254^1278). The two oligo-
nucleotides were paired to amplify a 792 bp product corresponding to
the 130^393 amino acid residues of the N-terminal PDE5 bovine lung
sequence. 35 PCR cycles were performed on cDNA after an initial
denaturing step of 10 min at 91‡C using the following pro¢le: 91‡C
for 1 min, 52‡C for 1 min, 72‡C for 2 min. The bovine lung, N18TG2
and NG108-15 ampli¢ed products obtained with the MI and MII
primers were named respectively MPDE5BL, MPDE5N18 and
MPDE5NG. In this notation the ¢rst letter identi¢es the primers
used for ampli¢cation and the ¢nal letters the source of mRNA
(BL for bovine lung, N18 and NG for the two neuroblastoma clones).
RT-PCR analysis was performed also on mouse N18TG2 total RNA
using two di¡erent sense and antisense oligonucleotide primers de-
signed on bovine lung PDE5 sequence. They were conventionally
denoted respectively as MCs (5P-AGG GAT CCA ATC CTG CTC
TTG CCC CTT GCAG-3P : nucleotides 298^320, with a BamHI site
added on 5P) and MCa (5P-GAG GAT CCT CAT AGG CGT CTT
TGA TGT TC-3P : nucleotides 788^816, with a BamHI site included)
(Biogen). These primers are more conserved with respect to the MI
and MII primers in the bovine and rat lung sequence [23,20]. The
resulting ampli¢ed 517 nucleotide fragment corresponds to the 68^
239 amino acid residues of the N-terminal bovine lung PDE5 se-
quence. The N18TG2 product ampli¢ed with MCs and MCa primers
was named MCPDE5N18. This ampli¢cation product was named
following the criteria outlined above, with MC indicating the primers
used in RT-PCR.
2.5. Cloning of the bovine lung and N18TG2 PDE5 cDNA fragments
The 792 bp PCR product MPDE5BL was inserted into the pCR-
Script vector (pCR-Script Amp SK(+) Cloning Kit, Stratagene) and
DH5K bacteria were transformed with the resulting vector construct.
The bovine lung cDNA insert was characterized by restriction analysis
(BamHI, HindIII) and sequenced by the dideoxynucleotide sequencing
method with Sequenase (United States Biochemical). The 517 bp PCR
product MCPDE5N18 was inserted into the pGEX-3X vector (Bam-
HI site) and cloned using DH5K bacteria. The sequence homology of
the mouse N18TG2 ampli¢ed product and bovine and rat lung clones
was veri¢ed by restriction analysis in conserved restriction sites (Hin-
dIII, EcoRI).
2.6. Northern blot analysis
Both PDE5 cDNA from bovine lung (MPDE5BL) and the neuro-
blastoma clone (MCPDEN18) were used in Northern blot analysis.
25 Wg of total RNA was fractionated on a formaldehyde/1.2% agarose
gel and transferred onto a Hybond-N nylon membrane (Amersham)
or an Immobilon-Ny+ nylon membrane (Millipore). Blots were pre-
hybridized at 45‡C for 3 h in QuiKHyb solution (Stratagene) and for
30 min in a solution containing 50% formamide, 6USSPE pH 7.4, SX
Denhardt’s solution, 5% dextran sulfate, 0.5% SDS, 0.5 mg/ml yeast
tRNA and 0.1 mg/ml of denaturated salmon sperm DNA. A random
hexanucleotide primer-labelled ([32P]dK-ATP) probe was prepared us-
ing both MPDE5BL, excized from pCR-Script by digestion with KpnI
and SacI, and MCPDE5N18 excized from pGEX-3X using BamHI
enzyme. Hybridization was performed overnight at 45‡C. Membranes
were washed for 30 min with 2USSPE, 0.1% SDS at room temper-
ature and twice with 0.1USSPE, 0.1% SDS at 50‡C. Blots were sub-
jected to autoradiography with BIOMAX-MS Kodak ¢lm for 32^48 h
or X-OMAT Kodak ¢lm for 120^144 h. Densitometric analysis was
performed using the Phoretix 1D program, which evaluates the band
volume as the sum of the intensity of every pixel in the band. To
normalize the RNA amount in the di¡erent lanes, blots, after probe
stripping, were hybridized with a 1.2 kb GAPDH fragment probe. Six
¢lters were hybridized under standard conditions for both probes and
the ratio of intensity of PDE5/GAPDH bands was used to normalise
the PDE5 band intensity. The standard error was calculated to eval-
uate analytical variations.
3. Results
NG108-15 neuroblastoma glioma hybrid cells respond to
cAMP extending neurites, expressing high levels of neuro-spe-
ci¢c proteins and establishing functional synapses [30,31,39].
When subjected to the same treatment, the parental neuro-
blastoma N18TG2 clone shows a similar morphological di¡er-
entiation, even though this is not accompanied by the induc-
tion of neurotransmission apparatus components [40].
Chromatographic analysis, studies of kinetic properties and
sensitivity to speci¢c inhibitors demonstrated the presence in
both clones of two PDE isoforms :PDE4 and PDE5. In both
cell lines their activity is higher in the presence of dbcAMP
[17,18]. The time course of PDE4 and PDE5 activity induction
suggested a possible involvement of transcription in the mech-
anisms of enzyme regulation activated by cAMP [18]. We
have focused our attention on the induction of PDE5 since
only post-translational regulation by cAMP has so far been
reported for this PDE isoform [35,36], while cAMP activation
of PDE4 transcription is known [33,34].
We produced cDNA PDE5 probes by RT-PCR, using
mRNA preparation from bovine lung (in which PDE5 has
¢rst been described and characterized). RT-PCR was then
also performed with N18TG2 and NG108-15 neuroblastoma
mRNA preparations. Both bovine and murine probes were
used to reveal speci¢c mRNA bands in undi¡erentiated and
dbcAMP treated N18TG2 and NG108-15 cells. PDE assays
were also performed on cultures run in parallel to those used
for RNA extraction. They con¢rmed that, following dbcAMP
treatment, both cell lines displayed a higher level of PDE5
(Table 1).
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Table 1
Induction of PDE5-speci¢c activities (nmoles cGMP hydrolysed/min/mg of protein) in N18TG2 and NG108-15 di¡erentiated cells
Clones PDE5 activity activity increase
Ctrl dbcAMP (fold)
N18TG2 0.157 þ 0.01 0.552 þ 0.05 3.5
NG108-15 0.083 þ 0.01 0.190 þ 0.03 2.3
Note: Ctrl = control cultures; dbcAMP = 5 days dbcAMP (5 mM) treated cultures.
Data are expressed as means þ S.E. (n = 6).
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3.1. RT-PCR production and cloning of a cDNA PDE5 probe
from bovine lung and neuroblastoma
MI and MII primers (see Section 2), designed on bovine
lung sequence [23], were selected to amplify a region within a
domain that shares a low level of homology with other PDE
families. The 792 bp fragment comprised by MI and MII
primers encodes 263 amino acid residues (130^393 in the bo-
vine lung protein) of the PDE5 N-terminal region. It contains
12 amino acid residues of the unique PDE5 sequence and 251
amino acid residues of the cGMP-binding region [23]. These
primers in RT-PCR, performed either on total (Fig. 1A) or
poly-A RNA from bovine lung, ampli¢ed the expected 792
bp fragment (MPDE5BL). The ampli¢ed fragment was ligated
into the plasmid vector pCR-Script Amp SK(+) and cloned in
DH5K. Restriction analysis with BamHI or HindIII gave frag-
ments of the expected size. Moreover, the sequence between
nucleotide 549 and 710 of the ampli¢ed fragment showed a
100% identity with the bovine lung PDE5 cDNA.
N18TG2 and NG108-15 total RNAs were also used in RT-
PCR using MI and MII as primers, to con¢rm the presence of
the PDE5 isoform in rodent neuronal cell lines. In both cases
an ampli¢ed fragment of 792 bp was obtained, showing the
same electrophoretic mobility as the bovine lung ampli¢ed
fragment (Fig. 1A). Restriction analysis of the neuroblastoma
ampli¢cation products gave the same results than bovine lung
products, indicating a substantial homology of neuroblastoma
and bovine lung PDE5 sequence.
Mouse N18TG2 RNA was also used in RT-PCR to amplify
another PDE5 region using two alternative primers, MCs and
MCa, highly conserved in the bovine and rat sequence (see
Section 2). A cDNA product of the expected length (517 bp)
was obtained (Fig. 1B) and cloned into pGEX-3X
(MCPDE5N18). In both the bovine and rat lung PDE5 se-
quence, the 517 bp fragment encodes 171 amino acid residues
in the N-terminal, 32 amino acids of the unique PDE5 se-
quence, and 139 amino acids of the cGMP-binding site
[23,20]. Also in this case restriction analysis con¢rmed a sub-
stantial homology of mouse neuroblastoma RT-PCR product
with bovine and rat lung sequences.
3.2. Expression of PDE5 mRNA upon dbcAMP-induced
di¡erentiation of N18TG2 and NG108-15 cells
To analyze the PDE5 mRNA level in neuroblastoma cells,
PDE5 cDNAs from both bovine lung (MPDE5BL) and
mouse neuroblastoma (MCPDE5N18) were used as probes
in Northern blots of total RNA extracted from dbcAMP-
treated and undi¡erentiated N18TG2 and NG108-15 cells.
Using the bovine lung probe (MPDE5BL), a speci¢c V9 kb
signal was revealed in bovine lung as well as in N18TG2 and
NG108-15 (Fig. 2A). The mouse neuroblastoma probe
(MCPDE5N18) recognized the same V9 kb transcript (Fig.
3A). Both probes revealed an increase of PDE5 mRNA in
NG108-15 cells as a result of dbcAMP treatment, while no
evident change was observed in N18TG2 cells. Densitometric
analysis was performed on the V9 kb bands to quantify the
level of PDE5 mRNA under the di¡erent culture conditions.
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Fig. 3. Expression of PDE5 mRNA in dbcAMP-treated neuroblas-
toma cells using the murine neuroblastoma probe (MCPDE5N18).
A: Northern blot analysis using 32P-labelled mouse neuroblastoma
PDE5 cDNA probe (MCPDE5N18, as described in Section 2). 25 Wg
of total RNAs from control and 5 days dbcAMP-treated N18TG2
cells (lane 1 and 2, respectively), control and dbcAMP-treated
NG108-15 cells (lanes 3 and 4, respectively). Markers are indicated
on the left of the panel. B: The same membrane was re-hybridized
with a 32P-labelled GAPDH probe to normalize the amount of
RNA.
Fig. 2. Expression of PDE5 mRNA in dbcAMP treated neuroblas-
toma cells using the bovine lung probe (MPDE5BL). A: Northern
blot analysis using 32P-labelled bovine lung PDE5 cDNA probe
(MPDE5BL, as described in Section 2). 25 Wg of total RNAs from
bovine lung (lane 1), control and 5 days dbcAMP-treated N18TG2
cells (lanes 2 and 3, respectively), control and dbcAMP-treated
NG108-15 cells (lanes 4 and 5, respectively). Markers are indicated
on the left of the panel. B: The same membrane was re-hybridized
with a 32P-labelled GAPDH probe to normalize the amount of
RNA.
Fig. 1. RT-PCR using speci¢c PDE5 primers performed on both
bovine and neuroblastoma RNAs. A: RT-PCR using MI and MII
PDE5-speci¢c primers (see Section 2) ampli¢ed a 792 bp fragment
from bovine lung RNAs (BL) as well as from neuroblastoma
N18TG2 (N18) and NG108-15 (NG) RNAs. B: RT-PCR using
MCs and MCa PDE5-speci¢c primers (see Section 2) ampli¢ed a
517 bp fragment from neuroblastoma N18TG2 RNA. Ampli¢ca-
tions were performed either with reverse transcriptase (+) or without
(3) as control.
D. Giordano et al./FEBS Letters 446 (1999) 218^222220
Normalization to the house-keeping gene GAPDH mRNA
(Fig. 2B, Fig. 3B) showed a 4.9-fold increase with respect to
control cells in NG108-15 (Fig. 4). No signi¢cant increase of
the PDE5 signal was observed in N18TG2 cells, although the
induction of enzymatic activity in these cells was even higher
than in NG108-15 (Fig. 4).
4. Discussion
RT-PCR analysis has shown a substantial homology of the
neuroblastoma and bovine lung PDE5 sequence [23], as indi-
cated by the same size (Fig. 1A) and restriction sites of the
ampli¢ed bands from neuroblastoma and lung mRNA. In
Northern blot, the probes obtained from bovine lung and
neuroblastoma cells in fact recognize the same transcript.
Both mouse and bovine cDNA probes were then used to
establish whether the di¡erentiating agent dbcAMP elicited a
higher transcription of the PDE5 gene, as suggested by the
timing of enzyme activity induction [18].
Northern blot analysis demonstrates that a 5-fold higher
level of PDE5 mRNA is found in dbcAMP treated NG108-
15 cells, providing the ¢rst evidence of a cAMP-dependent
induction of PDE5 expression. Until now only a cAMP-de-
pendent short term mechanism of PDE5 activation due to
PKA phosphorylation has been reported [35]. Recently it
has been shown that in airway smooth muscle cells PKA-
dependent activation of PDE5 can be prevented by the
PDE6 Q inhibitory subunit (PDE6Q). Two small proteins, im-
munologically related to PDE6Q, were found to be associated
to PDE5 and they were proposed as possible PDE5 regulatory
subunits [36,41]. A similar mechanism may be operating in
N18TG2 cells, where no increase in PDE5 mRNA level has
been observed. However, the timing of enzyme induction in
N18TG2 cells, which is not rapidly attained [18], is not con-
sistent with a post-translational regulation of the enzyme. It
may be therefore proposed that in these cells cAMP-induced
activation of PDE5 requires the transcriptional regulation of
an unknown regulatory element, possibly of the type de-
scribed in airway smooth cells [36].
In conclusion, modulation of the PDE5 activity in the two
cell lines appears to be dependent on the same signal, cAMP,
although two distinct mechanisms seem to be operating: di-
rect activation of PDE5 transcription in NG108-15, which is
not observed in N18TG2. It is conceivable that the di¡erent
behavior of the two cell lines is related to their di¡erent ability
to establish synaptic contacts [39]. In rat cerebellum, tran-
scriptional regulation of PDE5 during early postnatal devel-
opment has been reported and increased PDE5 expression has
been related to the development of cerebellar neuronal net-
works [20]. Thus our ¢ndings of a cAMP-induced transcrip-
tional regulation of PDE5 in NG108-15 and its absence in
N18TG2, may be consistent with a correlation between induc-
tion of PDE5 transcription and establishment of synaptic con-
tacts. Furthermore, our ¢ndings together with the reported
activation of PDE expression in rat cerebellum [20] and rat
lung [42] suggest that activation of PDE5 expression may be a
general phenomenon occurring during development and is
related to cell di¡erentiation and/or morphogenetic events in
various tissues.
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